Selexis’ Swiss investment in mammalian cell lines
Selexis SA has announced its cell line development laboratory will open this week in Geneva, Switzerland.
Selexis SA has announced its cell line development laboratory will open this week in Geneva, Switzerland.
A WuXi Biologics facility tipped to be the world’s largest single-use mammalian cell culture site will be equipped with disposable systems from Thermo Fisher.
Correction
A second single-use production line could offer commercial-scale capacity for bispecific antibodies but Glenmark says it would need to scale-up further to support more traditional biologics.
Amgen has teamed with Feldan Therapeutics and Elasmogen in an exclusive research agreement to develop and deliver intracellular biologics.